Skip to main content

Market Overview

Mid-Afternoon Market Update: Dow Drops Over 200 Points; Evolus Shares Plunge

Share:

Toward the end of trading Tuesday, the Dow traded down 0.82% to 26070.67 while the NASDAQ fell 0.11% to 10422.11. The S&P also fell, dropping 0.42% to 3,166.23.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 2,938,620 cases with around 130,300 deaths. Brazil confirmed a total of over 1,623,280 COVID-19 cases with 65,480 deaths, while India reported a total of at least 719,660 confirmed cases and 20,150 deaths. In total, there were at least 11,645,100 cases of COVID-19 worldwide with over 538,780 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares climbed 1.3% on Tuesday. Meanwhile, top gainers in the sector included United Natural Foods, Inc. (NASDAQ: UNFI), up 11%, and Walmart Inc. (NYSE: WMT), up 6%.

In trading on Tuesday, energy shares fell 1.9%.

Top Headline

Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected results for its fourth quarter.

Paychex reported quarterly earnings of $0.61 per share, beating analysts’ estimates of $0.60 per share. The company reported sales of $951.10 million, exceeding expectations of $910.91 million.

Paychex said it expects FY21 adjusted EPS to drop 6%-10% year-over-year and sales to drop 2%-5% year-over-year.

Equities Trading UP

Annovis Bio, Inc. (NYSE: ANVS) shares shot up 85% to $7.09 after the company received Central Institutional Review Board approval to initiate 15 site Phase 2 study in 68 Parkinson's and Alzheimer's patients.

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) got a boost, shooting 94% to $5.32 following an announcement concerning its foray into COVID-19 treatment. The company said the FDA has reviewed and accepted its investigational new drug application for initiating a COVID-19 study. Accordingly, the company said it has initiated a Phase 1 study to investigate a novel immunotherapy approach for patients with COVID-19.

Endologix, Inc. (NASDAQ: ELGX) shares were also up, gaining 46% to $0.37. Endologix shares dipped 67% on Monday after the company said it has initiated a voluntary Chapter 11 filing after undergoing a strategic review.

Equities Trading DOWN

Sino-Global Shipping America, Ltd. (NASDAQ: SINO) shares tumbled 25% to $2.18 following Q3 results. Sino-Global Shipping posted a quarterly loss of $0.22 per share, versus a year-ago loss of $0.09 per share.

Shares of Evolus, Inc. (NASDAQ: EOLS) were down 30% to $3.7150 after the company announced a administrative law judge will be overseeing the United States international trade commission case filed by Allergan and Medytox. The Judge released an initial determination finding a violation Section 337 Of The Tariff Act Of 1930. Evolus also said its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40 million in a five-year, unsecured, subordinated, 3% convertible note issued by the company at a conversion price of $13, which represents a 144% premium to the July 6 closing price. The investment will be funded before July 31, the company said.

Remark Holdings, Inc. (NASDAQ: MARK) was down, falling 23% to $1.99 after the company reported Q1 results.

Commodities

In commodity news, oil traded up 0.2% to $40.70, while gold traded up 0.9% to $1,809.10.

Silver traded up 0.5% Tuesday to $18.665, while copper rose 0.8% to $2.7965.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.61%, the Spanish Ibex Index fell 1.44%, while Italy’s FTSE MIB Index fell 0.10%. Meanwhile, the German DAX 30 declined 0.92%, French CAC 40 slipped 0.74% and UK shares fell 1.53%.

Economics

The number of job openings climbed by 401,000 to 5.397 million in May, the Labor Department reported.

The IBD/TIPP economic optimism index dropped to 44 in July versus 47 in June.

 

Related Articles (ANVS + CRVS)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com